Fubotv earnings beat by $0.10, revenue topped estimates
CHARLOTTE - On Thursday, Dentsply Sirona (NASDAQ:XRAY) reported second quarter earnings that exceeded analyst expectations, with adjusted earnings per share of $0.52 coming in above the consensus estimate of $0.50. The dental equipment manufacturer posted revenue of $936 million, slightly ahead of analysts’ projected $933.63 million, despite an overall decline from the same period last year.
The company’s shares rose 0.88% in after hours trading following the release.
Net sales decreased 4.9% compared to the second quarter of 2024, or 6.7% on a constant currency basis. The company cited a 3.2% negative impact from Byte sales. Revenue in the United States was particularly weak, falling 18.3%, while European sales increased 4.3% on a reported basis but decreased 0.4% in constant currency.
Shares of Dentsply Sirona rose 0.88% following the report, as investors responded positively to the company’s ability to beat expectations despite challenging conditions.
"I see tremendous opportunity at Dentsply Sirona and I am looking forward to digging in with the team to increase our customer-centric focus and to direct investments in areas that will generate sustainable growth," said Dan Scavilla, who was appointed Chief Executive Officer effective August 1, 2025.
The company recorded a GAAP net loss of -$0.22 per share, largely due to non-cash charges for the impairment of goodwill and other intangible assets totaling $214 million net of tax, or -$1.07 per share. These impairments were primarily driven by tariff impacts and lower volumes in implants, prosthetics, and equipment.
Despite revenue challenges, Dentsply Sirona improved its adjusted gross margin to 55.9%, up from 55.3% in the year-ago quarter. Adjusted EBITDA margin also expanded significantly to 21.1% from 17.5% last year.
"While top-line results were down in the quarter, we were pleased to continue to deliver margin expansion," said Matt Garth, Chief Financial Officer.
The company reaffirmed its full-year 2025 outlook, expecting revenue between $3.6 billion and $3.7 billion, representing a 2% to 4% decrease on a constant currency basis, and adjusted EPS in the range of $1.80 to $2.00.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.